WEIGAO GROUP Issues Overseas Regulatory Announcement on Subsidiary’s Shanghai Disclosure

Bulletin Express

Aug 25

Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) released an overseas regulatory announcement on 25 August 2026, informing shareholders that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange website (http://www.sse.com.cn/home/search/?webswd=688161).

The filing, made under Rule 13.10B of the Hong Kong Listing Rules, serves to synchronize information disclosure between Hong Kong and mainland Chinese markets. Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have expressly disclaimed responsibility for the contents of WEIGAO GROUP’s notice.

The announcement was authorized by Chairman Long Jing and lists the current composition of the Board: Executive Directors Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang and Sun Heng.

Further details of the subsidiary’s disclosure can be accessed through the Shanghai Stock Exchange link provided above.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1124303651"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1124303651\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1124303651?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-25 22:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1124303651","market":"us","top_or_hot":-1,"title":"WEIGAO GROUP Issues Overseas Regulatory Announcement on Subsidiary’s Shanghai Disclosure","media":"Bulletin Express","content":"<p>Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) released an overseas regulatory announcement on 25 August 2026, informing shareholders that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange website (http://www.sse.com.cn/home/search/?webswd=688161).</p>\n<p>The filing, made under Rule 13.10B of the Hong Kong Listing Rules, serves to synchronize information disclosure between Hong Kong and mainland Chinese markets. Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have expressly disclaimed responsibility for the contents of WEIGAO GROUP’s notice.</p>\n<p>The announcement was authorized by Chairman Long Jing and lists the current composition of the Board: Executive Directors Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang and Sun Heng.</p>\n<p>Further details of the subsidiary’s disclosure can be accessed through the Shanghai Stock Exchange link provided above.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>WEIGAO GROUP Issues Overseas Regulatory Announcement on Subsidiary’s Shanghai Disclosure</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWEIGAO GROUP Issues Overseas Regulatory Announcement on Subsidiary’s Shanghai Disclosure\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-25 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) released an overseas regulatory announcement on 25 August 2026, informing shareholders that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange website (http://www.sse.com.cn/home/search/?webswd=688161).</p>\n<p>The filing, made under Rule 13.10B of the Hong Kong Listing Rules, serves to synchronize information disclosure between Hong Kong and mainland Chinese markets. Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have expressly disclaimed responsibility for the contents of WEIGAO GROUP’s notice.</p>\n<p>The announcement was authorized by Chairman Long Jing and lists the current composition of the Board: Executive Directors Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang and Sun Heng.</p>\n<p>Further details of the subsidiary’s disclosure can be accessed through the Shanghai Stock Exchange link provided above.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01066","symbol_name":"威高股份","start_time":0,"source_url":"","article_id":"1124303651","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1124303651","pubTimestamp":1787669215,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) released an overseas regulatory announcement on 25 August 2026, informing shareholders that its subsidiary, Shandong Weigao...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01066":"威高股份"},"translate_title":"威高集团就子公司上海披露发布海外监管公告","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01066":1},"content_text":"Shandong Weigao Group Medical Polymer Company Limited (WEIGAO GROUP) released an overseas regulatory announcement on 25 August 2026, informing shareholders that its subsidiary, Shandong Weigao Orthopaedic Device Company Limited, has published an announcement on the Shanghai Stock Exchange website (http://www.sse.com.cn/home/search/?webswd=688161).\nThe filing, made under Rule 13.10B of the Hong Kong Listing Rules, serves to synchronize information disclosure between Hong Kong and mainland Chinese markets. Hong Kong Exchanges and Clearing Limited and the Stock Exchange of Hong Kong Limited have expressly disclaimed responsibility for the contents of WEIGAO GROUP’s notice.\nThe announcement was authorized by Chairman Long Jing and lists the current composition of the Board: Executive Directors Long Jing, Cong Rinan, Lu Junqiang and Wang Daoming; Non-executive Directors Chen Lin and Tang Zhengpeng; and Independent Non-executive Directors Li Guohui, Meng Hong, Li Qiang and Sun Heng.\nFurther details of the subsidiary’s disclosure can be accessed through the Shanghai Stock Exchange link provided above.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}